Cargando…
Idiopathic Pleuroparenchymal Fibroelastosis
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the devel...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119366/ https://www.ncbi.nlm.nih.gov/pubmed/35655629 http://dx.doi.org/10.14740/jmc3927 |
_version_ | 1784710686874533888 |
---|---|
author | Tavakolian, Kameron Udongwo, Ndausung Douedi, Steven Odak, Mihir Ilagan, Justin Khan, Taimoor Salam, Noor Chaughtai, Saira Asif, Arif |
author_facet | Tavakolian, Kameron Udongwo, Ndausung Douedi, Steven Odak, Mihir Ilagan, Justin Khan, Taimoor Salam, Noor Chaughtai, Saira Asif, Arif |
author_sort | Tavakolian, Kameron |
collection | PubMed |
description | Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management. |
format | Online Article Text |
id | pubmed-9119366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91193662022-06-01 Idiopathic Pleuroparenchymal Fibroelastosis Tavakolian, Kameron Udongwo, Ndausung Douedi, Steven Odak, Mihir Ilagan, Justin Khan, Taimoor Salam, Noor Chaughtai, Saira Asif, Arif J Med Cases Case Report Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management. Elmer Press 2022-05 2022-05-07 /pmc/articles/PMC9119366/ /pubmed/35655629 http://dx.doi.org/10.14740/jmc3927 Text en Copyright 2022, Tavakolian et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Tavakolian, Kameron Udongwo, Ndausung Douedi, Steven Odak, Mihir Ilagan, Justin Khan, Taimoor Salam, Noor Chaughtai, Saira Asif, Arif Idiopathic Pleuroparenchymal Fibroelastosis |
title | Idiopathic Pleuroparenchymal Fibroelastosis |
title_full | Idiopathic Pleuroparenchymal Fibroelastosis |
title_fullStr | Idiopathic Pleuroparenchymal Fibroelastosis |
title_full_unstemmed | Idiopathic Pleuroparenchymal Fibroelastosis |
title_short | Idiopathic Pleuroparenchymal Fibroelastosis |
title_sort | idiopathic pleuroparenchymal fibroelastosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119366/ https://www.ncbi.nlm.nih.gov/pubmed/35655629 http://dx.doi.org/10.14740/jmc3927 |
work_keys_str_mv | AT tavakoliankameron idiopathicpleuroparenchymalfibroelastosis AT udongwondausung idiopathicpleuroparenchymalfibroelastosis AT douedisteven idiopathicpleuroparenchymalfibroelastosis AT odakmihir idiopathicpleuroparenchymalfibroelastosis AT ilaganjustin idiopathicpleuroparenchymalfibroelastosis AT khantaimoor idiopathicpleuroparenchymalfibroelastosis AT salamnoor idiopathicpleuroparenchymalfibroelastosis AT chaughtaisaira idiopathicpleuroparenchymalfibroelastosis AT asifarif idiopathicpleuroparenchymalfibroelastosis |